BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27424719)

  • 1. Impact of smoking on lung cancer treatment effectiveness: a review.
    Condoluci A; Mazzara C; Zoccoli A; Pezzuto A; Tonini G
    Future Oncol; 2016 Sep; 12(18):2149-61. PubMed ID: 27424719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions with tobacco smoking. An update.
    Zevin S; Benowitz NL
    Clin Pharmacokinet; 1999 Jun; 36(6):425-38. PubMed ID: 10427467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically determined metabolism of nicotine and its clinical significance.
    Delijewski M; Bartoń A; Delijewska P; Balwierz R; Jakubiak G; Kośmider L; Pawlas N
    Acta Biochim Pol; 2019 Oct; 66(4):375-381. PubMed ID: 31584787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of smoking cessation in subjects with cancer: a 30-year review.
    Florou AN; Gkiozos IC; Tsagouli SK; Souliotis KN; Syrigos KN
    Respir Care; 2014 Dec; 59(12):1924-36. PubMed ID: 25185148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer.
    O'Malley M; King AN; Conte M; Ellingrod VL; Ramnath N
    J Thorac Oncol; 2014 Jul; 9(7):917-926. PubMed ID: 24926542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility.
    Du M; Xin J; Zheng R; Yuan Q; Wang Z; Liu H; Liu H; Cai G; Albanes D; Lam S; Tardon A; Chen C; Bojesen SE; Landi MT; Johansson M; Risch A; Bickeböller H; Wichmann HE; Rennert G; Arnold S; Brennan P; Field JK; Shete SS; Le Marchand L; Liu G; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Cox A; Hong YC; Yuan JM; Schabath MB; Aldrich MC; Wang M; Shen H; Chen F; Zhang Z; Hung RJ; Amos CI; Wei Q; Lazarus P; Christiani DC
    Cancer Res; 2024 Feb; 84(4):616-625. PubMed ID: 38117513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New molecular insights in tobacco-induced lung cancer.
    Tonini G; D'Onofrio L; Dell'Aquila E; Pezzuto A
    Future Oncol; 2013 May; 9(5):649-55. PubMed ID: 23647294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing cigarette, 1950-1995.
    Hoffmann D; Hoffmann I
    J Toxicol Environ Health; 1997 Mar; 50(4):307-64. PubMed ID: 9120872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapies for the prevention of lung cancer.
    Schachter EN; Neuman T
    Drugs Today (Barc); 2007 Dec; 43(12):897-936. PubMed ID: 18174975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco smoke induces production of chemokine CCL20 to promote lung cancer.
    Wang GZ; Cheng X; Li XC; Liu YQ; Wang XQ; Shi X; Wang ZY; Guo YQ; Wen ZS; Huang YC; Zhou GB
    Cancer Lett; 2015 Jul; 363(1):60-70. PubMed ID: 25864589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation: an integral part of lung cancer treatment.
    Cataldo JK; Dubey S; Prochaska JJ
    Oncology; 2010; 78(5-6):289-301. PubMed ID: 20699622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke.
    Waller LL; Miller AA; Petty WJ
    Lung Cancer; 2010 Jan; 67(1):12-6. PubMed ID: 19762110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cigarette smoking and lung cancer-elucidating an enigma].
    Ciornea L; Miron L; Ghiorghiu S
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):49-53. PubMed ID: 12092158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinogenic effect of tobacco smoke].
    Starek A; Podolak I
    Rocz Panstw Zakl Hig; 2009; 60(4):299-310. PubMed ID: 20361554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continued tobacco use during treatment of lung cancer.
    Waller LL; Weaver KE; Petty WJ; Miller AA
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1569-75. PubMed ID: 20942628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consequences of tobacco smoking on lung cancer treatments].
    Rivera C; Rivera S; Fabre E; Pricopi C; Le Pimpec-Barthes F; Riquet M
    Rev Pneumol Clin; 2016 Apr; 72(2):136-41. PubMed ID: 25727658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment.
    Martínez-García E; Irigoyen M; González-Moreno O; Corrales L; Teijeira A; Salvo E; Rouzaut A
    Toxicol Sci; 2010 Aug; 116(2):467-76. PubMed ID: 20457658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it more important to quit smoking than which chemotherapy is used?
    Dresler CM
    Lung Cancer; 2003 Feb; 39(2):119-24. PubMed ID: 12581562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of tobacco smoking on quality of life in patients with lung cancer].
    Underner M; Perriot J; Merson F; Peiffer G; Meurice JC
    Rev Mal Respir; 2015 Jun; 32(6):586-98. PubMed ID: 26231411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco, inflammation, and respiratory tract cancer.
    Milara J; Cortijo J
    Curr Pharm Des; 2012; 18(26):3901-38. PubMed ID: 22632749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.